Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Medical Research Collaborating Center, Seoul National University College of Medicine, Seoul, Korea.
Am J Kidney Dis. 2016 Jan;67(1):79-88. doi: 10.1053/j.ajkd.2015.06.027. Epub 2015 Sep 2.
High serum phosphorus levels are associated with cardiovascular morbidity and mortality in kidney disease. Although serum phosphorus levels possibly influence on mortality in individuals without kidney disease, this is uncertain because of the variable sex- and age-based distribution of serum phosphorus levels.
Observational cohort study.
SETTING & PARTICIPANTS: Clinical and biochemical data were collected from 138,735 adults undergoing routine health checkups in 3 tertiary hospitals. Individuals with estimated glomerular filtration rates < 60 mL/min/1.73 m2 and urine dipstick albumin ≥ 1+ were excluded.
Sex-specific quartiles of serum phosphorus and sex.
All-cause mortality.
The study included 92,756 individuals. Generally, women showed higher serum phosphorus levels than men. In women, serum phosphorus levels increased with age until 60 years old, then decreased with age. Men with higher serum phosphorus levels were younger and less likely to have hypertension, whereas women with higher serum phosphorus levels were older and more likely to have diabetes and hypertension. During a median follow-up of 75 months, 1,646 participants died. In the overall population, higher serum phosphorus levels were an independent predictor for all-cause mortality after adjustment (adjusted HR for the highest vs. lowest quartile, 1.34; 95% CI, 1.15-1.56; P<0.001). We observed that this increased risk was present in men but not in women (adjusted HR of 1.43 [95% CI, 1.22-1.68] vs. 1.01 [95% CI, 0.76-1.33]), but interaction by sex was not significant (P=0.8).
A single phosphorus measurement and low power to test for interactions by sex and age.
We demonstrated that higher serum phosphorus levels influenced all-cause mortality in individuals with normal kidney function. Our findings suggest that the association may differ by sex, but future studies with adequate power to test for effect modification are needed to confirm our findings.
高血清磷水平与肾脏病患者的心血管发病率和死亡率有关。尽管血清磷水平可能会影响无肾脏病患者的死亡率,但由于血清磷水平的性别和年龄分布存在差异,因此这种影响并不确定。
观察性队列研究。
从 3 家三级医院接受常规健康检查的 138735 名成年人中收集了临床和生化数据。排除估计肾小球滤过率<60mL/min/1.73m2和尿试纸白蛋白≥1+的个体。
血清磷的性别特异性四分位和性别。
全因死亡率。
这项研究纳入了 92756 名参与者。一般来说,女性的血清磷水平高于男性。在女性中,血清磷水平随着年龄的增长而增加,直到 60 岁,然后随着年龄的增长而降低。男性血清磷水平较高者年龄较小,患高血压的可能性较低,而女性血清磷水平较高者年龄较大,患糖尿病和高血压的可能性较高。在中位随访 75 个月期间,有 1646 名参与者死亡。在整个人群中,调整后较高的血清磷水平是全因死亡率的独立预测因素(最高四分位与最低四分位相比的调整后 HR,1.34;95%CI,1.15-1.56;P<0.001)。我们观察到,这种风险增加仅存在于男性,而不存在于女性(调整后 HR,1.43[95%CI,1.22-1.68]与 1.01[95%CI,0.76-1.33]),但性别间的交互作用不显著(P=0.8)。
单次磷测量和检验性别和年龄交互作用的能力较低。
我们表明,正常肾功能个体的较高血清磷水平会影响全因死亡率。我们的研究结果表明,这种关联可能因性别而异,但需要有足够能力检验效应修饰的未来研究来证实我们的发现。